THRB and ovarian carcinoma: THRB is associated with prognosis in various cancer entities and has been used in previous studies as a prognostic marker in cancers such as lung adenocarcinoma, high-grade plasmacytoma, ovarian cancer, and colorectal cancer [46,47,48].